Corcept Therapeutics (CORT)Director bought ~$2.5M

~$2.5M

Approx. value · 76K sh @ $33.00

1.12M

Holds after · shares reported

Traded

Mar 17, 2026

Filed

Mar 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 3, 2026InsiderOfficer sold ~$817K of CORT shares in the open market
2. Feb 24, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
3. Mar 4, 2026InsiderOfficer sold ~$296K of CORT shares in the open market
4. Mar 17, 2026 · this disclosureInsider · First insider buy since Jun 2021Director purchased ~$2.5M of CORT shares in the open market

What came next

1. Mar 17, 2026Insider · First insider buy since Jun 2021Director purchased ~$813K of CORT shares in the open market
2. Mar 20, 2026InsiderOfficer sold ~$424K of CORT shares in the open market
3. Mar 25, 2026InsiderCEO sold ~$1.31M of CORT shares in the open market
4. Apr 7, 2026InsiderOfficer sold ~$819K of CORT shares in the open market
5. Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
6. May 1, 2026InsiderCEO sold ~$2M of CORT shares in the open market
7. May 5, 2026InsiderOfficer sold ~$1.04M of CORT shares in the open market
8. May 21, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 21, 2026, Corcept Therapeutics Incorporated (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
9. May 27, 2026Insider · 2 peopleInsiders: 3 sales (~$5.2M)
10. Jun 1, 2026Insider · 3 peopleInsiders: 4 sales (~$5.5M)
11. Jun 2, 2026InsiderOfficer sold ~$1.41M of CORT shares in the open market
12. Jun 15, 2026Insider · 1 personInsiders: 4 sales (~$3.2M)
13. Jun 16, 2026Insider · 1 personInsiders: 2 sales (~$832K)
14. Jun 17, 2026InsiderDirector sold ~$1.69M of CORT shares in the open market
15. Jul 1, 2026Insider · 1 personInsiders: 3 sales (~$2.2M)
16. Jul 7, 2026Insider · 1 personInsiders: 2 sales (~$1.9M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Corcept Therapeutics

For Corcept Therapeutics, OQRO holds 64 insider filings (SEC Form 4 or Form 144) and 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CORT page.

Other recent filings by G Leonard Jr Baker, Director

• SEC Form 4 at Corcept Therapeutics (CORT)Mar 20, 2026

The full history of G Leonard Jr Baker, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Corcept Therapeutics

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026

Everything OQRO holds on this company is on its CORT page.